192 related articles for article (PubMed ID: 30515972)
1. LncRNA DUXAP9-206 directly binds with Cbl-b to augment EGFR signaling and promotes non-small cell lung cancer progression.
Zhu T; An S; Choy MT; Zhou J; Wu S; Liu S; Liu B; Yao Z; Zhu X; Wu J; He Z
J Cell Mol Med; 2019 Mar; 23(3):1852-1864. PubMed ID: 30515972
[TBL] [Abstract][Full Text] [Related]
2. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA JPX correlates with poor prognosis and tumor progression in non-small-cell lung cancer by interacting with miR-145-5p and CCND2.
Jin M; Ren J; Luo M; You Z; Fang Y; Han Y; Li G; Liu H
Carcinogenesis; 2020 Jul; 41(5):634-645. PubMed ID: 31253987
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of c-Cbl, Cbl-b and EGFR and its role of prognosis in NSCLC].
Jiao X; Jin B; Qu X; Yan S; Hou K; Liu Y; Hu X
Zhongguo Fei Ai Za Zhi; 2011 Jun; 14(6):512-7. PubMed ID: 21645455
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA CTD-2245E15.3 Promotes Anabolic Enzymes ACC1 and PC to Support Non-Small Cell Lung Cancer Growth.
Wang C; Meng X; Zhou Y; Yu J; Li Q; Liao Z; Gu Y; Han J; Linghu S; Jiao Z; Wang T; Zhang CY; Chen X
Cancer Res; 2021 Jul; 81(13):3509-3524. PubMed ID: 33941610
[TBL] [Abstract][Full Text] [Related]
6. E3 ubiquitin ligases Cbl-b and c-Cbl downregulate PD-L1 in EGFR wild-type non-small cell lung cancer.
Wang S; Xu L; Che X; Li C; Xu L; Hou K; Fan Y; Wen T; Qu X; Liu Y
FEBS Lett; 2018 Feb; 592(4):621-630. PubMed ID: 29364514
[TBL] [Abstract][Full Text] [Related]
7. linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancer.
Liu JQ; Feng YH; Zeng S; Zhong MZ
Life Sci; 2020 Jan; 241():117134. PubMed ID: 31811854
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p.
Li K; Jiang Y; Xiang X; Gong Q; Zhou C; Zhang L; Ma Q; Zhuang L
Thorac Cancer; 2020 May; 11(5):1180-1190. PubMed ID: 32147945
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin ligase Cbl-b is involved in icotinib (BPI-2009H)-induced apoptosis and G1 phase arrest of EGFR mutation-positive non-small-cell lung cancer.
Mu X; Zhang Y; Qu X; Hou K; Kang J; Hu X; Liu Y
Biomed Res Int; 2013; 2013():726375. PubMed ID: 23586056
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
Yu L; Chen D; Song J
Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA MGC27382 inhibits proliferation and metastasis of non-small cell lung cancer cells via down-regulating AKT/GSK3β pathway.
Li Q; Li S; Niu L; Yang S; Niu H; Cheng C
Clin Transl Oncol; 2021 Dec; 23(12):2548-2559. PubMed ID: 34224057
[TBL] [Abstract][Full Text] [Related]
12. The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling.
Lu Z; Li Y; Che Y; Huang J; Sun S; Mao S; Lei Y; Li N; Sun N; He J
Cancer Lett; 2018 Sep; 432():156-168. PubMed ID: 29908210
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
Li X; Zheng H
Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
[TBL] [Abstract][Full Text] [Related]
15. A SNP-mediated lncRNA (LOC146880) and microRNA (miR-539-5p) interaction and its potential impact on the NSCLC risk.
Feng T; Feng N; Zhu T; Li Q; Zhang Q; Wang Y; Gao M; Zhou B; Yu H; Zheng M; Qian B
J Exp Clin Cancer Res; 2020 Aug; 39(1):157. PubMed ID: 32795333
[TBL] [Abstract][Full Text] [Related]
16. m
Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
[TBL] [Abstract][Full Text] [Related]
17. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
[TBL] [Abstract][Full Text] [Related]
18. LIMD1-AS1 suppressed non-small cell lung cancer progression through stabilizing LIMD1 mRNA via hnRNP U.
Pan J; Tang Y; Liu S; Li L; Yu B; Lu Y; Wang Y
Cancer Med; 2020 Jun; 9(11):3829-3839. PubMed ID: 32239804
[TBL] [Abstract][Full Text] [Related]
19. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
[TBL] [Abstract][Full Text] [Related]
20. Suppressed expression of Cbl-b by NF-κB mediates icotinib resistance in EGFR-mutant non-small-cell lung cancer.
Zhang T; Zheng C; Hou K; Wang J; Zhang Y; Fan Y; Zhao H; Qu X; Liu Y; Kang J; Che X; Hu X
Cell Biol Int; 2019 Feb; 43(2):98-107. PubMed ID: 29972257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
